Rutka, Mariann; Bálint, Anita; Farkas, Klaudia; Palatka, Károly; Lakner L; Miheller, Pál; Racz I; Hegede G; Vincze, Áron; Horvath G; Szabo A; Nagy, Ferenc; Szepes, Zoltán; Gabor Z; Zsigmond F; Zsori A; Juhasz M; Csontos, Ágnes Anna; Szűcs, Mónika; Bor, Renáta; Milassin, Ágnes; Molnár, Tamás
(2016)
INTRODUCTION: Adalimumab was approved for the treatment of ulcerative colitis refractory to conventional therapy several years later than infliximab in Europe. Due to the relatively low remission rate observed in Ultra ...